Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I hear you on the performance review anxiety. It's definitely not just you. At Edwards, it feels like the focus has shifted pretty heavily toward metrics and demonstrable outcomes lately. The 'impact' and 'efficiency' buzzwords are everywhere. It's understandable that it's creating a sense of unease, especially when you feel the pressure from management filtering down. Hopefully, it's just a phase and not a permanent shift in how things are evaluated.
That heightened pressure during reviews is definitely a common sentiment across companies, and it seems to be particularly noticeable at Edwards Lifesciences this year. It's almost as if the overall economic climate or strategic shifts within the company are making leadership more scrutinizing. The shift in language from 'meeting goals' to 'impact' and 'efficiency' suggests a more outcome-oriented approach, which can feel like a higher bar. Hopefully, it leads to constructive feedback rather than just stress.